💉 Lilly widens RNA editing pact; Merck targets cancer; Merck too targets cancer

#244 | The Kable will be back in your inbox in 2023

Dec 23, 2022

∙ Paid

Hello, and welcome back to The Kable for what is our last issue of 2022. Thank you for reading The Kable all year long. We will be back on January 2nd, 2023 to take you through what could be a potentially world-changing year. Vaccines for malaria, herpes, RSV, Chikungunya are all on the anvil. Maybe Covid will actually be over, for real. Africa will be …

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.